What’s Next for PPD Treatment | Inhaled Mebufotenin (GH001) Phase 2a Results Kristina Deligiannidis, MD, presents phase 2a results for inhaled GH001 (mebufotenin), a psychedelic-based therapeutic that produced same-day remission of postpartum depression in an open-label trial, with rapid clearance from breast milk. The post What’s Next for PPD Treatment | Inhaled Mebufotenin (GH001) Phase 2a Results appeared first on Psychiatrist.com .